Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Myeloid Leukemia (Relapsed/Refractory)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00732316
What this trial is testing

Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematologic Cancer or Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Asan Medical Center 54
Early research (Phase 1)Looking for participantsNCT07306832
What this trial is testing

Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
AbbVie 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07091006
What this trial is testing

Efficacy and Safety of VAH as a Bridging Regimen to Allo-HCT in Relapsed/Refractory AML

Who this might be right for
Relapse Leukemia
Ruijin Hospital 44
Testing effectiveness (Phase 2)Study completedNCT00066599
What this trial is testing

Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy

Who this might be right for
Kidney CancerLeukemiaLymphoma+6 more
National Cancer Institute (NCI)
Early research (Phase 1)Looking for participantsNCT05735184
What this trial is testing

Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Who this might be right for
Acute Myeloid LeukemiaMixed Lineage Leukemia Gene MutationRefractory AML+7 more
Kura Oncology, Inc. 420
Testing effectiveness (Phase 2)UnknownNCT05807347
What this trial is testing

Venetoclax Combined With Azacitidine and CAG in Refractory/Relapse Acute Myeloid Leukemia

Who this might be right for
Refractory/Relapse Acute Myeloid Leukemia
Hematology department of the 920th hospital 42
Testing effectiveness (Phase 2)Looking for participantsNCT06680752
What this trial is testing

Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS

Who this might be right for
Acute Myeloid Leukemia, in RelapseAcute Myeloid Leukemia RefractoryMDS (Myelodysplastic Syndrome)
ARCE Therapeutics, Inc. 49
Testing effectiveness (Phase 2)Ended earlyNCT02520011
What this trial is testing

Alvocidib Biomarker-driven Phase 2 AML Study

Who this might be right for
Acute Myeloid Leukemia
Sumitomo Pharma America, Inc. 104
Early research (Phase 1)Ended earlyNCT02882321
What this trial is testing

Oxidative Phosphorylation Inhibitor IACS-010759 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Recurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
M.D. Anderson Cancer Center 17
Very early researchLooking for participantsNCT06762132
What this trial is testing

A Clinical Study to Explore the Safety and Efficacy of CD33 CAR-T Cell in Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Zhejiang University 27
Testing effectiveness (Phase 2)Study completedNCT00109707
What this trial is testing

Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies

Who this might be right for
Chronic Myelogenous LeukemiaAcute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)Hypereosinophilic Syndrome+1 more
Novartis Pharmaceuticals 507
Testing effectiveness (Phase 2)Ended earlyNCT06563804
What this trial is testing

Evaluate S227928 as a Single Agent and in Combination With Venetoclax in Patients With R/R AML, MDS/AML, or CMML

Who this might be right for
Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)/AMLChronic Myelomonocytic Leukemia (CMML)
Servier Bio-Innovation LLC 13
Not applicableUnknownNCT02619071
What this trial is testing

ChEmo-Genomics Based Treatment of Acute Myeloid Leukemia

Who this might be right for
Leukemia, Myeloid, Acute
Institut Paoli-Calmettes 87
Early research (Phase 1)Ended earlyNCT00852709
What this trial is testing

Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias

Who this might be right for
Myelodysplastic SyndromeAcute Myeloid LeukemiaMyeloproliferative Disorders+7 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Not applicableStudy completedNCT05541224
What this trial is testing

A Retrospective Epidemiologic Registry to Gain Insight Into the Characteristics and Prognosis of AML Patients According to the Routinely Used Genetic and Biologic Markers

Who this might be right for
Acute Myeloid Leukemia
PETHEMA Foundation 6,917
Early research (Phase 1)Not Yet RecruitingNCT07441980
What this trial is testing

A Clinical Study to Explore the Safety and Efficacy of CT1390B in Relapsed/ Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia(AML)
Institute of Hematology & Blood Diseases Hospital, China 18
Early research (Phase 1)UnknownNCT02799680
What this trial is testing

Allogeneic CART-33 for Relapsed/Refractory CD33+ AML

Who this might be right for
Relapsed and/or Refractory CD33+ AML
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 12
Testing effectiveness (Phase 2)Looking for participantsNCT06125652
What this trial is testing

Administration of Anti Tim-3/CD123 CAR-T Cell Therapy in Relapsed and Refractory Acute Myeloid Leukemia (rr/AML)

Who this might be right for
Acute Myeloid Leukemia RefractoryAcute Myeloid Leukemia, in Relapse
Xuzhou Medical University 20
Testing effectiveness (Phase 2)UnknownNCT00036712
What this trial is testing

Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+9 more
Medical College of Wisconsin 80
Early research (Phase 1)Study completedNCT03263936
What this trial is testing

Epigenetic Reprogramming in Relapse/Refractory AML

Who this might be right for
Acute Myelogenous Leukemia
Therapeutic Advances in Childhood Leukemia Consortium 37
Next Page